Mylan to improve Morgantown

Mylan has “committed to a robust improvement plan” as part of its response to a 32-page ‘Form 483’ issued by the US Food and Drug Administration (FDA) to highlight observations and deficiencies at the firm’s flagship facility in Morgantown, US. The company has full confidence in the quality, safety and efficacy of the site’s products.